• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉血管舒缩功能检测的原则与陷阱。

Principles and pitfalls in coronary vasomotor function testing.

机构信息

Department of Clinical and Experimental Cardiology, Amsterdam UMC, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.

出版信息

EuroIntervention. 2022 Feb 18;17(15):1271-1280. doi: 10.4244/EIJ-D-21-00402.

DOI:10.4244/EIJ-D-21-00402
Abstract

BACKGROUND

Coronary vasomotor dysfunction can be diagnosed in a large proportion of patients with angina in the presence of non-obstructive coronary artery disease (ANOCA) using comprehensive protocols for coronary vasomotor function testing (CFT). Although consensus on diagnostic criteria for endotypes of coronary vasomotor dysfunction has been published, consensus on a standardised study testing protocol is lacking.

AIMS

In this review we provide an overview of the variations in CFT used and discuss the practical principles and pitfalls of CFT.

METHODS

For the purposes of this review, we assessed study protocols that evaluate coronary vasomotor response as reported in the literature. We compared these protocols regarding a number of procedural aspects and chose six examples to highlight the differences and uniqueness.

RESULTS

Currently, numerous protocols co-exist and vary in vascular domains tested, the manner in which to test these domains (e.g., preprocedural discontinuation of medication, provocative agent, solution, infusion time, and target artery) and techniques used for measurements (e.g., Doppler vs thermodilution technique).

CONCLUSIONS

This lack of consensus on a uniform functional testing protocol hampers both a broader clinical acceptance of the concepts of coronary vasomotor dysfunction, and the widespread adoption of such testing protocols in current clinical practice. Furthermore, the endotype of coronary vasomotor dysfunction might differ among the few specialised centres that perform CFT as a result of the use of different protocols.

摘要

背景

在存在非阻塞性冠状动脉疾病(ANOCA)的情况下,使用综合的冠状动脉血管舒缩功能测试(CFT)方案,可以在很大一部分心绞痛患者中诊断出冠状动脉血管舒缩功能障碍。尽管已经发表了关于冠状动脉血管舒缩功能障碍内型的诊断标准共识,但缺乏标准化研究测试方案的共识。

目的

在这篇综述中,我们概述了所使用的 CFT 的变化,并讨论了 CFT 的实际原则和陷阱。

方法

为了进行本次综述,我们评估了文献中报道的评估冠状动脉血管舒缩反应的研究方案。我们比较了这些方案在多个程序方面,并选择了六个示例来突出差异和独特性。

结果

目前,有许多方案同时存在,在测试的血管域、测试这些域的方式(例如,术前停药、激发剂、溶液、输注时间和靶动脉)以及用于测量的技术(例如,多普勒与热稀释技术)方面存在差异。

结论

缺乏统一的功能测试方案的共识,既阻碍了冠状动脉血管舒缩功能障碍概念的更广泛临床接受,也阻碍了此类测试方案在当前临床实践中的广泛应用。此外,由于使用不同的方案,进行 CFT 的少数专门中心之间的冠状动脉血管舒缩功能障碍内型可能存在差异。

相似文献

1
Principles and pitfalls in coronary vasomotor function testing.冠状动脉血管舒缩功能检测的原则与陷阱。
EuroIntervention. 2022 Feb 18;17(15):1271-1280. doi: 10.4244/EIJ-D-21-00402.
2
Protocol Variation in Functional Coronary Angiography Among Patients With Suspected Angina With Non-Obstructive Coronary Arteries: A Nationwide Snapshot of Current Practice Within Australia and New Zealand.疑似非阻塞性冠状动脉疾病心绞痛患者的功能性冠状动脉造影术方案差异:澳大利亚和新西兰当前实践的全国快照。
Heart Lung Circ. 2024 Sep;33(9):1287-1296. doi: 10.1016/j.hlc.2024.04.299. Epub 2024 Jun 30.
3
Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).荷兰侵入性冠状动脉血管舒缩功能检测登记研究(NL-CFT)的设计与原理。
Int J Cardiol. 2023 May 15;379:1-8. doi: 10.1016/j.ijcard.2023.02.043. Epub 2023 Feb 28.
4
Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.血管舒缩功能障碍在心绞痛和非阻塞性冠状动脉疾病患者中主要表现为血管痉挛。
Int J Cardiol. 2021 Jun 15;333:14-20. doi: 10.1016/j.ijcard.2021.02.079. Epub 2021 Mar 10.
5
Absolute coronary blood flow across different endotypes of ANOCA.不同 ANOCA 表型的冠状动脉绝对血流量。
EuroIntervention. 2024 Oct 7;20(19):e1227-e1236. doi: 10.4244/EIJ-D-24-00111.
6
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.地尔硫䓬改善非冠状动脉粥样硬化性急性冠状动脉综合征患者冠状动脉血管运动功能障碍的疗效:EDIT-CMD 随机临床试验。
JACC Cardiovasc Imaging. 2022 Aug;15(8):1473-1484. doi: 10.1016/j.jcmg.2022.03.012. Epub 2022 Apr 2.
7
Prevalence of Coronary Vasomotor Disorders in Patients With Angina and Nonobstructive Coronary Arteries: A Sydney Experience.心绞痛伴非阻塞性冠状动脉疾病患者的冠状动脉舒缩功能障碍患病率:悉尼经验。
Heart Lung Circ. 2024 Sep;33(9):1297-1306. doi: 10.1016/j.hlc.2024.02.020. Epub 2024 Jun 25.
8
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.非对称性二甲基精氨酸可预测无阻塞性冠状动脉疾病的心绞痛患者的心外膜冠状动脉舒缩功能障碍。
Int J Cardiol. 2020 Jan 15;299:7-11. doi: 10.1016/j.ijcard.2019.07.062. Epub 2019 Jul 19.
9
Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing.在有创性冠状动脉功能试验中,比较冠状动脉内乙酰胆碱输注与乙酰胆碱弹丸注射方案的诊断效果。
Am J Cardiol. 2024 Apr 15;217:49-58. doi: 10.1016/j.amjcard.2024.01.038. Epub 2024 Feb 28.
10
Quantification of Absolute Myocardial Flow and Resistance by Continuous Thermodilution in Patients with Ischemia and Nonobstructive Coronary Artery Disease (INOCA).应用连续热稀释法对缺血但非阻塞性冠状动脉疾病(INOCA)患者进行绝对心肌血流和阻力的定量评估。
J Vis Exp. 2021 Apr 24(170). doi: 10.3791/62066.

引用本文的文献

1
Expanding diagnostic horizons: the role of multivessel coronary function testing in angina with non-obstructive coronary arteries.拓展诊断视野:多支冠状动脉功能检测在非阻塞性冠状动脉疾病所致心绞痛中的作用
Cardiovasc Diagn Ther. 2025 Jun 30;15(3):522-525. doi: 10.21037/cdt-24-476. Epub 2025 Jun 24.
2
Optimizing the diagnostic yield of invasive coronary function testing.优化有创冠状动脉功能测试的诊断率
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):5-10. doi: 10.21037/cdt-24-426. Epub 2025 Feb 25.
3
More testing, more findings: the evolving story of coronary vascular dysfunction.

本文引用的文献

1
Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm.乙酰胆碱再挑战:冠状动脉痉挛患者个体化治疗的第一步。
JACC Cardiovasc Interv. 2022 Jan 10;15(1):65-75. doi: 10.1016/j.jcin.2021.10.003.
2
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.欧洲心脏病学会与冠状动脉病理生理学和微循环工作组合作的 EAPCI 专家共识文件,缺血与非阻塞性冠状动脉,由冠状动脉血管舒缩障碍国际研究小组认可。
EuroIntervention. 2021 Jan 20;16(13):1049-1069. doi: 10.4244/EIJY20M07_01.
3
更多检测,更多发现:冠状动脉血管功能障碍的演变历程
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):11-14. doi: 10.21037/cdt-24-549. Epub 2025 Feb 25.
4
Coronary Endothelial Dysfunction and Vasomotor Dysregulation in Myocardial Bridging.心肌桥中的冠状动脉内皮功能障碍与血管舒缩调节异常
J Cardiovasc Dev Dis. 2025 Feb 2;12(2):54. doi: 10.3390/jcdd12020054.
5
Coronary Myocardial Bridge Updates: Anatomy, Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Options.冠状动脉心肌桥的最新进展:解剖、病理生理学、临床表现、诊断及治疗选择
Tex Heart Inst J. 2025 Jan 30;52(1):e238300. doi: 10.14503/THIJ-23-8300. eCollection 2025 Jan-Jun.
6
Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina.在血管痉挛性心绞痛中,心绞痛严重程度和症状改善与诊断性乙酰胆碱激发剂量相关。
J Am Heart Assoc. 2025 Jan 21;14(2):e037913. doi: 10.1161/JAHA.124.037913. Epub 2025 Jan 16.
7
Invasive Evaluation for Coronary Vasospasm.冠状动脉痉挛的侵入性评估
US Cardiol. 2023 Jun 9;17:e07. doi: 10.15420/usc.2022.33. eCollection 2023.
8
Do electrocardiographic changes induced during intracoronary vasospasm provocation testing reflect those during spontaneous angina episodes in patients with vasospastic angina?: a case series.冠状动脉痉挛激发试验期间诱发的心电图变化是否反映了变异性心绞痛患者自发性心绞痛发作时的心电图变化?:病例系列研究
Eur Heart J Case Rep. 2024 Aug 1;8(8):ytae386. doi: 10.1093/ehjcr/ytae386. eCollection 2024 Aug.
9
Do changes in intracoronary pressure aid coronary spasm diagnosis using the spasm provocation test?冠状动脉内压力变化是否有助于通过痉挛激发试验诊断冠状动脉痉挛?
World J Cardiol. 2024 Jan 26;16(1):16-26. doi: 10.4330/wjc.v16.i1.16.
10
Coronary spasm and vasomotor dysfunction as a cause of MINOCA.冠状动脉痉挛和血管舒缩功能障碍是 MINOCA 的病因。
EuroIntervention. 2024 Jan 15;20(2):e123-e134. doi: 10.4244/EIJ-D-23-00448.
Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries.
与冠状动脉正常的稳定型心绞痛患者相比,冠状动脉正常的心肌梗死患者进行冠状动脉痉挛激发试验的安全性评估及结果
Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):380–387. doi: 10.1177/2048872620932422. Epub 2020 Jun 8.
4
Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity.冠状动脉痉挛:内皮功能障碍与血管平滑肌细胞高反应性之间的相互作用
Eur Cardiol. 2020 Apr 6;15:e12. doi: 10.15420/ecr.2019.20. eCollection 2020 Feb.
5
Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease).稳定型缺血性心脏病(非阻塞性冠状动脉疾病和阻塞性冠状动脉疾病)中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):771-786. doi: 10.1093/cvr/cvaa005.
6
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
7
Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory.在导管实验室诊断心绞痛和非阻塞性冠心病患者。
Heart. 2019 Oct;105(20):1536-1542. doi: 10.1136/heartjnl-2019-315042. Epub 2019 Jul 31.
8
Dose maximal acetylcholine dose into the left coronary artery affect the positive provoked spasm in the left circumflex artery?向左冠状动脉内注射最大乙酰胆碱剂量是否会影响左旋支动脉激发的阳性痉挛?
Coron Artery Dis. 2019 Nov;30(7):547-548. doi: 10.1097/MCA.0000000000000756.
9
Prevalence of Microvascular and Endothelial Dysfunction in the Nonculprit Territory in Patients With Acute Myocardial Infarction.急性心肌梗死患者非罪犯病变部位的微血管和内皮功能障碍的患病率。
Circ Cardiovasc Interv. 2019 Feb;12(2):e007257. doi: 10.1161/CIRCINTERVENTIONS.118.007257.
10
Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina.非阻塞性冠状动脉所致心肌梗死:聚焦于变异性心绞痛
Neth Heart J. 2019 May;27(5):237-245. doi: 10.1007/s12471-019-1232-7.